These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An update on the treatment of myelodysplastic syndromes. Kurtin SE; Demakos EP Clin J Oncol Nurs; 2010 Jun; 14(3):E29-44. PubMed ID: 20529786 [TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies]. Aul C; Giagounidis A; Germing U; Ganser A Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275 [TBL] [Abstract][Full Text] [Related]
5. When to treat myelodysplastic syndromes. Akhtari M Oncology (Williston Park); 2011 May; 25(6):480-6. PubMed ID: 21717901 [TBL] [Abstract][Full Text] [Related]
6. Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes? Steensma DP Best Pract Res Clin Haematol; 2012 Dec; 25(4):443-51. PubMed ID: 23200541 [TBL] [Abstract][Full Text] [Related]
7. Optimal sequencing of treatments for patients with myelodysplastic syndromes. Itzykson R; Fenaux P Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268 [TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management. Garcia-Manero G Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Myelodysplastic Syndromes: A Review. Sekeres MA; Taylor J JAMA; 2022 Sep; 328(9):872-880. PubMed ID: 36066514 [TBL] [Abstract][Full Text] [Related]
12. [Myelodysplastic syndromes]. Geissler K Wien Med Wochenschr; 1991; 141(9-10):201-4. PubMed ID: 1949844 [TBL] [Abstract][Full Text] [Related]
13. Myelodysplasia: when to treat and how. Larson RA Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126 [TBL] [Abstract][Full Text] [Related]
14. Management of myelodysplastic syndromes: 2008 update. Scott BL; Estey E Oncology (Williston Park); 2008 Nov; 22(12):1344-52. PubMed ID: 19086598 [TBL] [Abstract][Full Text] [Related]
16. [Current management of myelodysplastic syndromes]. Vey N; Charbonnier A Rev Prat; 2010 Dec; 60(10):1416-9. PubMed ID: 21425543 [TBL] [Abstract][Full Text] [Related]
17. Incorporating novel agents in the treatment of myelodysplastic syndromes. Anargyrou K; Vassilakopoulos TP; Angelopoulou MK; Terpos E Leuk Res; 2010 Jan; 34(1):6-17. PubMed ID: 19656566 [TBL] [Abstract][Full Text] [Related]
18. [Recent advances in therapy of myelodysplastic syndromes]. Hu QJ; Chen BA Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1522-5. PubMed ID: 23257466 [TBL] [Abstract][Full Text] [Related]
19. Refractory anemia and the myelodysplastic syndromes. Lawrence LW Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893 [TBL] [Abstract][Full Text] [Related]
20. The myelodysplastic syndromes: the era of understanding. Meers S Eur J Haematol; 2015 May; 94(5):379-90. PubMed ID: 25186093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]